1. Home
  2. Directory
  3. Wisconsin
  4. Brookfield
  5. Colon Rectal Surgery
  6. NPI Profile
  7. Prescriptions 1669727921

DR. THERESE G. KERWEL MD
Prescription History 1669727921
Colon & Rectal Surgery in Brookfield, WI


Quality Rating: 82.39 out of 100 score

NPI Status: Active since July 23, 2012

Contact Information

17000 W NORTH AVE
SUITE 107W
BROOKFIELD, WI
ZIP 53005
Phone: (262) 785-7740

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. THERESE G. KERWEL MD, an active Colon & Rectal Surgery specialist practicing in Brookfield, WI. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 60 documented patient claims. Among these therapy options, the most frequently utilized medication is Sod Sulf-Potass Sulf-Mag Sulf, which accounts for 29 claims alone.

Medication Index

M
O
S
No matching medications currently found on file.

Movantik

Generic Formulation: Naloxegol OxalateSpecialty: General Surgery
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
WI State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills19.5
Peer Average Days Supply537
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,027.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$418.93

State Avg Cost Per Claim

$455.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat constipation caused by opioid medications in people with ongoing pain that is not caused by cancer. It blocks the effect of opioids on the gut without blocking the effect on pain. Naloxegol belongs to a class of drugs known as opioid antagonists.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: General Surgery
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 105
WI State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills44.7
Peer Average Days Supply790
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 56.8% less volume than the regional standard for practitioners inside WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $74.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.92

State Avg Cost Per Claim

$20.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Sod Sulf-Potass Sulf-Mag Sulf

Generic Formulation: Sodium, Potassium,mag SulfatesSpecialty: General Surgery
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 36
WI State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills27.2
Peer Average Days Supply35
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,257.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$77.84

State Avg Cost Per Claim

$81.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sodium/potassium/magnesium sulfate solution is used to clean out the intestines before a certain bowel exam procedure (colonoscopy). It is a laxative that works by drawing large amounts of water into the colon. This causes watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. THERESE G. KERWEL MD provides transparency into local medical care patterns within Brookfield, WI.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Colon & Rectal Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.